Schonfeld Strategic Advisors LLC Purchases 52,500 Shares of Edap Tms S.A. (NASDAQ:EDAP)

Schonfeld Strategic Advisors LLC raised its position in shares of Edap Tms S.A. (NASDAQ:EDAP) by 48.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 160,800 shares of the medical equipment provider’s stock after acquiring an additional 52,500 shares during the period. Schonfeld Strategic Advisors LLC owned approximately 0.43% of Edap Tms worth $355,000 at the end of the most recent quarter.

Separately, Illumine Investment Management LLC bought a new stake in shares of Edap Tms during the fourth quarter worth approximately $50,000. 62.74% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on EDAP. StockNews.com began coverage on Edap Tms in a report on Wednesday, May 7th. They set a “hold” rating for the company. HC Wainwright restated a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a report on Friday, March 28th. Jefferies Financial Group restated a “hold” rating and set a $2.00 price objective (down previously from $8.00) on shares of Edap Tms in a report on Friday, April 4th. Finally, Piper Sandler cut their price target on Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research note on Friday, March 28th.

Edap Tms Trading Up 0.5%

Shares of EDAP stock opened at $2.22 on Monday. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The stock has a market cap of $82.37 million, a P/E ratio of -3.42 and a beta of 0.13. The stock has a 50 day simple moving average of $1.96 and a 200 day simple moving average of $2.27. Edap Tms S.A. has a 1 year low of $1.26 and a 1 year high of $7.11.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.06. The business had revenue of $22.69 million during the quarter, compared to analysts’ expectations of $20.83 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. On average, research analysts predict that Edap Tms S.A. will post -0.6 earnings per share for the current fiscal year.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.